Microfluidic Modulation Spectroscopy (MMS) measures previously undetectable changes in protein structure

Two new studies that support MMS for characterising mAbs and for predicting biomolecule secondary structure are now available!     Advancing Secondary Structure Characterisation of Monoclonal Antibodies using MMS ACCESS HERE Progress in Infrared Spectroscopy as an Efficient Tool for Predicting Protein Secondary Structure ACCESS HERE   Discover how MMS can strengthen your bioanalytical tool kit by providing critical insight through all phases of protein-based drug development.   MMS provides ultrasensitive, highly reproducible, automated structural measurements of proteins and other biomolecules. Able to differentiate <2% change in HOS, the technique can be used for a wide range of applications from formulation development of mAb-based biotherapeutics to robust measurements of ADCs, AAVs, and mRNA.  Please contact Peter Davis (Email: pdavis@atascientific.com.au  or call direct (0417 778 971) should you have any questions or requests.   DOWNLOAD A COPY OF THE BROCHURE   MMS for Predicting Aggregation & Particle Formation Behaviour During Early Formulation   Insights into predicting aggregation and particle formation behaviour during early formulation screening: The Role of MMS by Rob Forbes, PhD, University of Central Lancashire/ Fujifilm Diosynth Biotechnologies. Watch this  presentation now available on-demand. WATCH NOW